![[Search]](/static/images/search.gif){kind=small}
![[A-Z Index]](/static/images/az.gif){kind=small}
![[Contact]](/static/images/contact.gif){kind=small}
![[University of Cambridge]](/static/images/identifier2.gif){kind=small}
![[Talks.cam]](/static/images/talkslogosmall.gif)
Dr Matthew Coghlan & Dr Ricardo Samms - Eli Lilly
Tuesday 24 September 2019, 13:15-14:15
“Elucidating the role of GIP receptor agonism in the therapeutic efficacy of Tirzepatide”
⚠️ Important: Refreshments available from 13.00
- 👤 Speaker: Dr Matthew Coghlan & Dr Ricardo Samms - Eli Lilly
- 📅 Date & Time: Tuesday 24 September 2019, 13:15 - 14:15
- 📍 Venue: Institute of Metabolic Science (IMS), Level 4 ATC, Seminar rooms 1,2 & 3
Questions? Contact
Karen Laurence
Abstract
Abstract not available
Series This talk is part of the ims-mrl external research seminar series.
Included in Lists
- ims-mrl external research seminar
- Institute of Metabolic Science (IMS), Level 4 ATC, Seminar rooms 1,2 & 3
Note: Ex-directory lists are not shown.